Suchergebnisse - "Katarzyna Szklener"

PubPharm (9)

1

Stereotactic radiosurgery in the treatment of essential tremor – a systematic review

in: Frontiers in Neurology | 2024

von Mateusz Bilski | Mateusz Bilski | Mateusz Bilski | +11

2

Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives

in: International Journal of Molecular Sciences | 2023

von Katarzyna Szklener | Anna Rudzińska | Pola Juchaniuk | +2

3

Phytochemicals in Cancer Treatment and Cancer Prevention—Review on Epidemiological Data and Clinical Trials

in: Nutrients | 2023

von Anna Rudzińska | Pola Juchaniuk | Jakub Oberda | +4

4

Impact of COVID-19 pandemic on therapy in cancer patients

in: Journal of Education, Health and Sport | 2022

von Katarzyna Szklener | Anna Rodzajewska | Weronika Kuryło | +1

5

Squamous cell carcinoma as a primary pleural tumor – case report

in: Journal of Education, Health and Sport | 2022

von Katarzyna Szklener | Agnieszka Kopystecka | Patrycja Hatala | +3

6

Unexpectedly long progression-free time in a patient with squamous cell carcinoma of the lung treated with Nivolumab – a case study.

in: Journal of Education, Health and Sport | 2022

von Katarzyna Szklener | Klaudia Piwowar | Jakub Klas | +2

7

Chemoembolization as a minimally invasive treatment of primary malignant liver cancer

in: Journal of Education, Health and Sport | 2022

von Katarzyna Szklener | Weronika Kuryło | Anna Rodzajewska | +3

8

Atypical age of onset of the small bowel adenocarcinoma – case report

in: Journal of Education, Health and Sport | 2022

von Katarzyna Szklener | Maria Maciąg | Aleksandra Marczak | +2

9

New Directions in the Therapy of Glioblastoma

in: Cancers | 2022

von Katarzyna Szklener | Marek Mazurek | Małgorzata Wieteska | +3

1
[1]